Previous 10 | Next 10 |
2023-12-10 13:04:00 ET More on AbCellera Biologics, Absci, etc. AbCellera: Difficult 2023 Suggests Business Model Should Pivot In 2024 Buy AbCellera Biologics's Revolutionizing AI-Powered Drug Development Platform Certara, Inc. 2023 Q3 - Results - Earnings Call Prese...
2023-12-10 08:00:00 ET More on AI's impact Nvidia Shares Now Look Cheap (Rating Upgrade) Snowflake's Data Marketplace: The Key To Unlocking The Potential Of Generative AI Microsoft Corporation (MSFT) Presents at Barclays Global Technology Conference (Transcript) ...
2023-12-06 14:31:18 ET More on Simulations Plus Big Pharma's AI Ambitions: The Countdown For Simulations Plus Begins Simulations Plus Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Simulations Plus Historical earnings data for Simulat...
2023-11-15 11:15:00 ET Summary Equity markets declined in Q3 2023 as concerns over higher interest rates and a potential recession grew. Large-cap stocks outperformed small-cap stocks, largely due to the strong performance of mega-cap technology stocks. Conestoga's small-cap g...
Demonstrates How Putting Clients First Drives Growth and Fuels Innovation Reiterates 2024 Guidance Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of modeling and simulation software and services for pharmaceutical safety and eff...
Amparo de la Peña, Vice President of Pharmacometrics at Simulations Plus, will join Jeff Sachs, Pavan Vaddady and Hao Zhu as new board members for 2024 Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical and bio...
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of modeling and simulation software and services for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that it will hold a virtual Investor Day on Tuesday, Novemb...
2023-10-26 13:38:28 ET Summary Simulations Plus reported strong Q4 2023 results, with an 11% YoY revenue growth and a 33% increase compared to the previous quarter. The company's valuation is high compared to its financials and growth prospects, and it faces intense competition fr...
2023-10-25 22:13:08 ET Simulations Plus, Inc. (SLP) Q4 2023 Earnings Conference Call Oct 25, 2023, 05:00 PM ET Company Participants Tamara Gonzales - Investor Relations, Financial Profiles Shawn O'Connor - Chief Executive Officer Will Frederick - Chief Financial ...
2023-10-25 16:15:31 ET More on Simulations Plus Seeking Alpha’s Quant Rating on Simulations Plus Historical earnings data for Simulations Plus Dividend scorecard for Simulations Plus Financial information for Simulations Plus For further detail...
News, Short Squeeze, Breakout and More Instantly...
2024-05-14 03:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-04 09:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Shares of Reliance Global Group, Inc. (NASDAQ: RELI) fell sharply in today’s pre-market trading after reporting financial results for ...